Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5829|16|1|E76-E82

ISSN: 1476-5810

Source: VETERINARY AND COMPARATIVE ONCOLOGY, Vol.16, Iss.1, 2018-03, pp. : E76-E82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract